Presidential Portfolio Surges Amid Controversial Drug Pricing Exemptions
Congressional Democrats are raising alarms over a massive spike in President Donald Trump’s pharmaceutical investments following his return to the White House. According to a report from the Joint Economic Committee’s minority…
Read the story →











